/* Product view custom css */

Pharmed Limited - Unlisted Shares

Master

Pharmed Limited - Unlisted Shares

Face Value 2
ISIN No INE0EEI01017

You Can Buy The Below Quantity From Us By Clicking On “Buy Now” Or For More & Bulk Quantity, You Can Contact Us On: 02249369990 / 09867572101 / 09987204585
ID Face Value Quantity Rate Amount Mode Minimum Lot Size  
For more details contact us on 02249369990 / 09867572101 / 09987204585

Company Information

Pharmed Limited Unlisted Shares



Board of Directors

Chairman

: Suneet Aurora

Independent Director

: S N Agrawal

Independent Director

: Dr Jagdish Chinnappa



Background:

Pharmed is one of the fastest-growing pharmaceutical companies in India. For over 7 decades, Pharmed is a name to reckon with in the therapy areas of women's health; reproductive health; joint, bone and tendon health; pain management; cardio diabetic health; ear, nose, throat health; urogenital health; digestive health; immune health and general health Pharmed focuses on Orthopedic Surgery, Gynaecology & Obstetrics, ENT, Internal Medicine and General Practice Therapy Areas.


Registered Office:

Pharmed House 141 Walchand, hirachand marg , Mumbai Maharashtra india 40001.


INCORPORATION YEAR

: 1946

WEBSITE

: www.pharmedlimited.com

EMAIL

: co.law@pharmed.in

CIN NO

: U24230MH1946PLC005121

ISIN NO.

: INE0EEI01017

SECTOR

: Healthcare

FACE VALUE

: 2

PROMOTER HOLDING

: 92%


Consolidated Financial Information for Last 3 Years (Rupees In Crore)

Particulars

2022

2021

2020

Equity Capital

0.86

0.86

0.86

Reserve & Surplus

198.74

159.44

122.17

Net worth

199.60

160.30

123.03

Book Value Per share Rs.

463.52

372.79

285.71

Total Income

359.62

286.25

319.92

Profit

42.32

37.38

23.98

EPS Rs.

98.28

86.93

55.68


Annual Report of Pharmed Limited Unlisted Shares

Pharmed Limited Annual Report 2022

Pharmed Limited Annual Report 2021

Pharmed Limited Annual Report 2020

Cookie Consent

We use cookies to ensure you have the best browsing experience on our website. By using our site, you acknowledge that you have read and understood our Cookie Policy & Privacy